Related Experiment Video
Updated: Jul 20, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Transforming growth factor-beta pathway disruption and infiltration of colorectal cancers by intraepithelial
K Baker1, G Chong, W D Foulkes
1Department of Pathology, SMBD-Jewish General Hospital, Department of Oncology and Human Genetics, McGill University, Montreal, QC, Canada. kristi.baker@mcgill.ca
Aims:
Colorectal cancers deficient in DNA mismatch repair (MMR) are often characterized by the presence of numerous intraepithelial lymphocytes (IELs). These CD8+ T cells selectively express CD103, which is upregulated locally by transforming growth factor (TGF)-beta, and adhere to E-cadherin expressed by mucosal epithelia. Many of these cancers also possess inactivating mutations in the type II TGF-beta receptor and are believed to be insensitive to TGF-beta. The present study aimed to explore whether such refractoriness to TGF-beta is an independently contributing factor to IEL retention.
Methods And Results:
A panel of colorectal cancers enriched for DNA MMR deficiency was examined by immunohistochemistry to explore the expression levels and localization of various components in the TGF-beta signalling pathway. Logistic regression was then carried out in order to identify predictors of elevated lymphocytic infiltration independent of DNA MMR status. Increases in Smad4 expression, tumour cell proliferation and TGF-beta secretion each emerged as independent predictors of marked lymphocyte infiltration.
Conclusions:
These results strongly support the hypothesis that refractoriness to normal TGF-beta signalling in colorectal cancers plays a role in the retention of lymphocytes within tumour epithelium. Since IEL infiltration is an independent predictor of favourable prognosis, the TGF-beta pathway may represent an important therapeutic target.
Insights
Colorectal cancers with DNA mismatch repair deficiency retain lymphocytes due to transforming growth factor-beta (TGF-beta) pathway insensitivity. This TGF-beta refractoriness, linked to better prognosis, suggests targeting this pathway for cancer therapy.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Colorectal cancers deficient in DNA mismatch repair (MMR) often exhibit numerous intraepithelial lymphocytes (IELs).
- These CD8+ T cells express CD103, upregulated by transforming growth factor-beta (TGF-beta), and bind to E-cadherin on mucosal epithelia.
- Many MMR-deficient cancers have mutations in the TGF-beta type II receptor, suggesting TGF-beta insensitivity.
Purpose of the Study:
- To investigate if refractoriness to TGF-beta signaling contributes to IEL retention in colorectal cancers.
- To identify predictors of increased lymphocytic infiltration independent of MMR status.
Main Methods:
- Immunohistochemistry was used to analyze TGF-beta pathway components in MMR-deficient colorectal cancers.
- Logistic regression analysis identified predictors of elevated lymphocytic infiltration.
Main Results:
- Increased Smad4 expression was an independent predictor of marked lymphocyte infiltration.
- Tumor cell proliferation and TGF-beta secretion also independently predicted higher lymphocyte infiltration.
- These factors were identified independently of DNA mismatch repair status.
Conclusions:
- Refractoriness to TGF-beta signaling in colorectal cancers plays a role in retaining lymphocytes within the tumor epithelium.
- IEL infiltration is an independent predictor of a favorable prognosis.
- The TGF-beta pathway represents a potential therapeutic target for colorectal cancer.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
TGF - β Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Renewal of Intestinal Stem Cells

